ULTRA RAPID-ACTING INHALED INSULIN IMPROVES GLUCOSE CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ULTRA RAPID-ACTING INHALED INSULIN IMPROVES GLUCOSE CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Authors
Keywords
-
Journal
Endocrine Practice
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-01
DOI
10.1016/j.eprac.2020.10.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
- (2020) Laura Mayeda et al. BMJ Open Diabetes Research & Care
- Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes
- (2020) Jee Hee Yoo et al. Diabetes Technology & Therapeutics
- Understanding Inhaled Technosphere Insulin: Results of an Early Randomized Trial in Type 1 Diabetes Mellitus
- (2020) Janet B. McGill et al. Journal of Diabetes
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
- (2019) Tadej Battelino et al. DIABETES CARE
- Controversies for Glucose Control Targets in Type 2 Diabetes: Exposing the Common Ground
- (2019) Philip Home DIABETES CARE
- Time in range is associated with carotid intima-media thickness in type 2 diabetes
- (2019) Jingyi Lu et al. Diabetes Technology & Therapeutics
- Positioning time in range in diabetes management
- (2019) Andrew Advani DIABETOLOGIA
- cgmanalysis: An R package for descriptive analysis of continuous glucose monitor data
- (2019) Tim Vigers et al. PLoS One
- Hypoglycaemia is reduced with use of inhaled Technosphere ® Insulin relative to insulin aspart in type 1 diabetes mellitus
- (2019) E. R. Seaquist et al. DIABETIC MEDICINE
- HbA1c
- (2019) Anders L. Carlson et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
- (2018) Jingyi Lu et al. DIABETES CARE
- Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study
- (2018) Halis Kaan Akturk et al. Diabetes Technology & Therapeutics
- Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
- (2018) Roy W. Beck et al. DIABETES CARE
- Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin
- (2016) K. Khunti et al. DIABETES OBESITY & METABOLISM
- Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial
- (2015) Bruce W. Bode et al. DIABETES CARE
- Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents
- (2015) Julio Rosenstock et al. DIABETES CARE
- AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
- (2015) Alan J. Garber et al. Endocrine Practice
- Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review
- (2015) C. J. Ng et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Challenges Associated with Insulin Therapy in Type 2 Diabetes Mellitus
- (2014) Steven Edelman et al. AMERICAN JOURNAL OF MEDICINE
- Dosing Irregularities and Self-Treated Hypoglycemia in Type 2 Diabetes: Results from the Canadian Cohort of an International Survey of Patients and Healthcare Professionals
- (2014) Lawrence A. Leiter et al. Canadian Journal of Diabetes
- Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses
- (2012) Meryl Brod et al. CURRENT MEDICAL RESEARCH AND OPINION
- Insulin pharmacokinetics following dosing with Technosphere insulin in subjects with chronic obstructive pulmonary disease
- (2010) Elizabeth Potocka et al. CURRENT MEDICAL RESEARCH AND OPINION
- Population Pharmacokinetic Model of Human Insulin Following Different Routes of Administration
- (2010) Elizabeth Potocka et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
- (2010) Julio Rosenstock et al. LANCET
- Barriers to Insulin Injection Therapy
- (2009) Richard R. Rubin et al. DIABETES EDUCATOR
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now